Cargando…
Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [(18)F]FDGal PET/CT
PURPOSE: Stereotactic body radiotherapy (SBRT) is increasingly used for treatment of liver tumors but the effect on metabolic liver function in surrounding tissue is largely unknown. Using 2-deoxy-2-[(18)F]fluoro-d-galactose ([(18)F]FDGal) positron emission tomography (PET)/computed tomography (CT),...
Autores principales: | Sørensen, Michael, Fode, Mette Marie, Petersen, Jørgen Baltzer, Holt, Marianne Ingerslev, Høyer, Morten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485519/ https://www.ncbi.nlm.nih.gov/pubmed/34598730 http://dx.doi.org/10.1186/s13014-021-01909-z |
Ejemplares similares
-
Metabolic liver function measured in vivo by dynamic (18)F-FDGal PET/CT without arterial blood sampling
por: Horsager, Jacob, et al.
Publicado: (2015) -
[(18)F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer
por: Pasqualetti, Francesco, et al.
Publicado: (2019) -
The impact of (18) F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesions
por: Badakhshi, Harun, et al.
Publicado: (2014) -
[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results
por: Pasqualetti, Francesco, et al.
Publicado: (2016) -
Clinical utility of texture analysis of 18F-FDG PET/CT in patients with Stage I lung cancer treated with stereotactic body radiotherapy
por: Takeda, Kazuya, et al.
Publicado: (2017)